Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXXC5 Antisense RNA 1 (CXXC5-AS1) is a long non-coding RNA gene transcribed antisense to the CXXC5 locus. Antisense long non-coding RNAs such as CXXC5-AS1 can regulate gene expression, often through epigenetic mechanisms including chromatin modification or transcriptional interference. There is limited specific functional information, but based on the class of molecule, CXXC5-AS1 is likely involved in gene regulatory processes. Its pathological significance, including in cancer, remains largely speculative and under investigation, with no current evidence supporting its use as a therapeutic or biomarker target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CXXC5 Antisense RNA 1 (CXXC5-AS1).